Continuation of First-Line Systemic Therapy with Progression-Directed Radiotherapy in Patients with Oligoprogressive Hepatocellular Carcinoma: A Multicenter, Single-Arm, Phase II Trial
Abstract Purpose: Evidence for radiotherapy (RT) in oligoprogressive hepatocellular carcinoma (OP-HCC) is limited. We evaluated the efficacy and safety of progression-directed RT (PDRT) alongside…
Read the full article10d agoen
You might also wanna read
Returning to PARP Inhibition: Rechallenge with Bevacizumab in Ovarian Cancer
aacrjournals.org·10d ago
Targeted Radiation, Unintended Evolution
aacrjournals.org·10d ago
Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
aacrjournals.org·10d ago
NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas
aacrjournals.org·10d ago
Preoperative Chemoimmunotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab for Previously Irradiated Recurrent HNSCC: A Prospective Phase II Trial
aacrjournals.org·10d ago
The Pan-Tumor Landscape of Gene Amplifications and Copy Number Amplification Ratio for Established and Emerging Clinical Targets
aacrjournals.org·10d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.